Brandywine Financial Group Buys 72,649 Shares of Colgate-Palmolive Company $CL

Key Points

• Brandywine Financial Group increased its Colgate-Palmolive stake by 35,612.3%, purchasing 72,649 additional shares to hold 72,853 shares valued at approximately $6.2 million. Institutional investors own 80.41% of the company.
• Colgate-Palmolive reported adjusted EPS of $0.99, topping the $0.95 consensus estimate, while revenue rose 4.9% year over year to $5.36 billion. However, GAAP EPS fell 5%, organic sales growth was modest, and North American demand remained weak.
• Analysts maintain a “Moderate Buy” consensus rating with an average price target of $97.82, while management reaffirmed its full-year sales outlook. The company also declared a quarterly dividend of $0.53, equivalent to a 2.3% annualized yield.

Brandywine Financial Group grew its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 35,612.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 72,853 shares of the company's stock after purchasing an additional 72,649 shares during the period. Colgate-Palmolive comprises approximately 5.3% of Brandywine Financial Group's investment portfolio, making the stock its 11th largest position. Brandywine Financial Group's holdings in Colgate-Palmolive were worth $6,209,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Kemnay Advisory Services Inc. bought a new position in Colgate-Palmolive in the 4th quarter valued at approximately $25,000. CBIZ Investment Advisory Services LLC grew its stake in shares of Colgate-Palmolive by 86.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company's stock worth $26,000 after buying an additional 150 shares during the last quarter. TD Capital Management LLC increased its holdings in shares of Colgate-Palmolive by 61.4% during the fourth quarter. TD Capital Management LLC now owns 326 shares of the company's stock worth $26,000 after buying an additional 124 shares in the last quarter. Triumph Capital Management increased its holdings in shares of Colgate-Palmolive by 62.9% during the fourth quarter. Triumph Capital Management now owns 329 shares of the company's stock worth $26,000 after buying an additional 127 shares in the last quarter. Finally, Jessup Wealth Management Inc bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at $26,000. 80.41% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently weighed in on CL. Sanford C. Bernstein assumed coverage on Colgate-Palmolive in a research report on Thursday, June 11th. They set a "market perform" rating and a $96.00 price objective on the stock. Morgan Stanley reiterated an "overweight" rating on shares of Colgate-Palmolive in a research report on Monday, May 4th. Barclays lifted their price target on Colgate-Palmolive from $80.00 to $87.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 21st. The Goldman Sachs Group reaffirmed a "buy" rating on shares of Colgate-Palmolive in a research note on Friday, May 1st. Finally, JPMorgan Chase & Co. raised their price objective on shares of Colgate-Palmolive from $96.00 to $104.00 and gave the company an "overweight" rating in a report on Thursday, July 16th. Twelve equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of "Moderate Buy" and a consensus target price of $97.82.

Colgate-Palmolive Price Performance

Shares of CL opened at $91.29 on Monday. The business has a 50-day moving average of $90.97 and a 200-day moving average of $89.49. The company has a debt-to-equity ratio of 16.33, a current ratio of 0.45 and a quick ratio of 0.30. The company has a market capitalization of $73.05 billion, a price-to-earnings ratio of 36.23, a price-to-earnings-growth ratio of 4.80 and a beta of 0.33. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%.The business had revenue of $5.36 billion for the quarter, compared to analysts' expectations of $5.36 billion. During the same period in the prior year, the business posted $0.92 earnings per share. The firm's revenue was up 4.9% on a year-over-year basis. As a group, equities research analysts anticipate that Colgate-Palmolive Company will post 3.82 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be paid a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Monday, July 20th. Colgate-Palmolive's dividend payout ratio is currently 82.49%.

Colgate-Palmolive News Roundup

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Second-quarter adjusted/base-business EPS was $0.99, exceeding the $0.95 consensus estimate and rising from $0.92 a year earlier. Revenue increased 4.9% year over year to $5.36 billion, in line with expectations. Colgate-Palmolive Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Profitability improved, with GAAP and base-business gross margins expanding 140 basis points to 61.5%. Productivity gains and organic sales growth helped offset increased brand investment, while Latin America led regional growth and toothpaste maintained its global leadership. Colgate Q2 Earnings Beat Estimates on Strong Margins
• Neutral Sentiment: Management reaffirmed its full-year sales forecast, with expected revenue of approximately $20.8 billion to $21.6 billion. Maintaining guidance supports stability, but the range signals limited visibility in a choppy consumer environment. Colgate-Palmolive Reaffirms Annual Sales Forecast
• Negative Sentiment: North American demand remained muted, creating concern that the company’s strongest international performance may not fully offset weakness in its largest developed market. Investors also focused on management’s warning that new tariffs could outweigh a recent refund benefit, potentially pressuring future earnings. Colgate Warns New Tariffs Will Outweigh Recent Refund Windfall
• Negative Sentiment: GAAP EPS declined 5% to $0.86 despite the adjusted earnings beat, and organic sales growth was only 2.4%. The combination of slower underlying growth, domestic weakness and tariff risk is outweighing the quarter’s positive margin and earnings performance.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.